摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cerium triacetate | 537-00-8

中文名称
——
中文别名
——
英文名称
Cerium triacetate
英文别名
cerium(3+);triacetate
Cerium triacetate化学式
CAS
537-00-8
化学式
C6H9CeO6
mdl
——
分子量
317.25
InChiKey
VGBWDOLBWVJTRZ-UHFFFAOYSA-K
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    308°C (dec.)
  • 沸点:
    decomposes [CRC10]
  • LogP:
    2.35
  • 物理描述:
    DryPowder; OtherSolid, Liquid
  • 稳定性/保质期:

    按规格使用和贮存,不会发生分解,避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    -3.73
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    120
  • 氢给体数:
    0
  • 氢受体数:
    6

ADMET

毒理性
  • 副作用
纤维原性 - 引发组织损伤和纤维化(疤痕形成)。
Fibrogenic - Inducing tissue injury and fibrosis (scarring).
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

安全信息

  • TSCA:
    No

SDS

SDS:247e8c22a2cfb23da4f55b10d2690828
查看

Section 1: Product Identification
Chemical Name: Cerium (III) acetate, hydrate(99.9%-Ce) (REO)
CAS Registry Number: 537-00-8
Formula: Ce(OOCCH3)3.XH2O
EINECS Number: 208-654-0
Chemical Family: metal acetate salt
Synonym: Acetic acid, cerium(3+) salt, cerium triacetate

Section 2: Composition and Information on Ingredients
Ingredient CAS Number Percent ACGIH (TWA) OSHA (PEL)
Title Compound 537-00-8 100% no data no data

Section 3: Hazards Identification
Emergency Overview: Irritating to eyes, skin and respiratory tract. May be harmful if swallowed.
Primary Routes of Exposure: Ingestion
Eye Contact: Causes slight to mild irritation of the eyes.
Skin Contact: Causes slight to mild irritation of the skin.
Inhalation: Irritating to the nose, mucous membranes and respiratory tract.
Ingestion: No information on the physiological effects of ingestion.
Acute Health Affects: Irritating to skin, eyes and respiratory tract.
Chronic Health Affects: No information available on long-term chronic effects.
NTP: No
IARC: No
OSHA: No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in
Inhalation:
breathing, coughing, wheezing or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point: not applicable
Autoignition Temperature: none
Explosion Limits: none
Extinguishing Medium: carbon dioxide or dry powder
If this product is involved in a fire, firefighters should be equipped with NIOSH approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion and If involved in a fire this material may emit toxic and corrosive fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazard.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures: Small spills can be mixed with powdered sodium carbonate or ground limestone and swept up.

SECTION 7: Handling and Storage
Handling and Storage: Store the material in a sealed container. Keep away from heat and moisture.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection: Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection: Wear appropriate chemical resistant gloves and protective clothing.
Ventilation: Material may form a fine dust. If possible, handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respiratory
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation: Material may form a fine dust. If possible, handle the material in an efficient fume hood.
Additional Protection: No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form: white powder
Molecular Weight: 317.26
Melting Point: no data
Boiling Point: no data
Vapor Pressure: no data
Specific Gravity: no data
Odor: none
Solubility in Water: insoluble

SECTION 10: Stability and Reactivity
Stability: air and moisture stable
Hazardous Polymerization: no hazardous polymerization
Conditions to Avoid: none
Incompatibility: oxidizing agents
Decomposition Products: carbon monoxide, carbon dioxide, cerium oxide and organic fumes

SECTION 11: Toxicological Information
RTECS Data: Intravenous (human); TDLo: 2mg/kg
Carcinogenic Effects: no data
Mutagenic Effects: no data
Tetratogenic Effects: no data

SECTION 12: Ecological Information
Ecological Information: No information available

SECTION 13: Disposal Considerations
Disposal: Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR): Non-hazardous
Hazard Class (CFR): NA
Additional Hazard Class (CFR): NA
Packaging Group (CFR): NA
UN ID Number (CFR): NA
Shipping Name (IATA): Non-hazardous
Hazard Class (IATA): NA
Additional Hazard Class (IATA): NA
Packaging Group (IATA): NA
UN ID Number (IATA): NA

SECTION 15: Regulatory Information
TSCA: Listed in the TSCA inventory
SARA (Title 313): Title compound not listed.
Second Ingredient: none


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途 用于汽车尾气净化和催化剂等。

类别 有毒物质

毒性分级 高毒

急性毒性 静脉注射于人:LD50为2毫克/公斤

可燃性危险特性 对神经系统有害,热分解时产生辛辣刺激烟雾

储运特性 库房应低温、通风干燥,并与食品原料分开存放

灭火剂 二氧化碳、泡沫、干粉

反应信息

点击查看最新优质反应信息

文献信息

  • Novel catalyst for selective NOx reduction using hydrocarbons
    申请人:Marshall L. Christopher
    公开号:US20050101473A1
    公开(公告)日:2005-05-12
    A two phase catalyst is disclosed with one or more transition metals such as Cu, Co, Fe, Ag and Mo supported on a molecular sieve having a pore size not greater than 8 Å along with a stabilizing oxide of one or more of the oxides of Zr, Mo, V, Nb or the rare earths coating the molecular sieve. A method of preparing the two phase catalyst and using same to remediate NO x in combustion gases is also described.
    本发明公开了一种两相催化剂,其中一种或多种过渡属(如Cu、Co、Fe、Ag和Mo)支持在具有孔径不大于8Å的分子筛上,并且一种或多种Zr、Mo、V、Nb或稀土氧化物的稳定氧化物包覆在分子筛上。还描述了制备该两相催化剂的方法,并将其用于治理燃烧废气中的NOx。
  • Process for the manufacture of glycols and glycol nono-esters
    申请人:Montedison S.p.A.
    公开号:US04061868A1
    公开(公告)日:1977-12-06
    There is provided an improvement in the process for the preparation of organic monoesters of vicinal glycols and the corresponding free glycols by reacting an olefin with oxygen, water and a carboxylic acid, in the liquid phase, at an initial pH of lower than 7, the improvement comprising contacting the reaction mixture with a catalyst system consisting essentially of (i) iodine or an iodine compound selected from the group consisting essentially of copper iodide, manganese iodide, cerium iodide, an alkali metal iodide, an alkali earth metal iodide and the iodohydride of the olefin, (ii) a copper compound selected from the group consisting essentially of copper oxide, copper hydroxide, copper carbonate, copper iodide, and a copper salt of the carboxylic acid, and (iii) an activating ion selected from the group consisting of manganese cation, cerium cation, an alkali metal cation, an alkaline earth metal cation, nitric anion or a mixture of any of the foregoing, wherein the molar ratio of the carboxylic acid to water is lower than 1, the molar ratio of copper to water is equal to or lower than 2 moles of copper per 100 moles of water, and the molar ratio of iodine to copper is lower than 1.
    提供了一种改进的方法,用于制备有机单酯和相应的游离二元醇,通过在液相中将烯烃与氧气羧酸反应,在初始pH小于7的条件下,改进包括将反应混合物与催化剂系统接触,催化剂系统主要包括(i)或从化物、化物、化物、碱化物、碱土化物和烯烃的氢化物中选择的化合物,(ii)从氧化铜氢氧化铜碳酸羧酸盐中选择的化合物,以及(iii)从阳离子、阳离子、碱属阳离子、碱土属阳离子、硝酸根离子或任何上述离子的混合物中选择的活化离子,其中羧酸的摩尔比小于1,的摩尔比等于或小于2摩尔/100摩尔的摩尔比小于1。
  • Catalyst support material having high oxygen storage capacity and method of preparation thereof
    申请人:——
    公开号:US20020132732A1
    公开(公告)日:2002-09-19
    Mixed oxides of cerium oxide and zirconium oxides having a high oxygen storage and high oxygen release rate are disclosed. The mixed oxides are made of polycrystalline particles of cerium oxide and zirconium oxide having a controlled domain structure on the subcrystalline level wherein adjacent domains within a single crystallite have a different ratio of zirconium and cerium. The mixed oxides are prepared by a co-precipitation technique using mixed salt solutions of cerium and zirconium having a solid content of at least 23%, based on an oxide basis.
    本发明公开了具有高氧储存和高氧释放速率的氧化铈氧化锆混合氧化物。混合氧化物由具有受控领域结构的氧化铈氧化锆的多晶颗粒组成,在单个晶粒内相邻的领域具有不同的氧化锆氧化铈比例。混合氧化物是通过使用固体含量至少为23%(以氧化物为基础)的混合盐溶液的共沉淀技术制备的。
  • Catalyst for selective NOx reduction using hydrocarbons
    申请人:UChicago Argonne, LLC
    公开号:US07220692B2
    公开(公告)日:2007-05-22
    A two phase catalyst is disclosed with one or more transition metals such as Cu, Co, Fe, Ag and Mo supported on a molecular sieve having a pore size not greater than 8 Å along with a stabilizing oxide of one or more of the oxides of Zr, Mo, V, Nb or the rare earths coating the molecular sieve. A method of preparing the two phase catalyst and using same to remediate NOx in combustion gases is also described.
    揭示了一种双相催化剂,其中包含一种或多种过渡属,例如Cu、Co、Fe、Ag和Mo,支持在具有孔径不大于8Å的分子筛上,并且还有一种或多种稳定氧化物的涂层,这些氧化物包括Zr、Mo、V、Nb或稀土元素的氧化物。还描述了制备这种双相催化剂的方法,并使用它来净化燃烧气中的NOx。
  • FUKUZAWA SHIN-ICHI; FUJINAMI TATSUO; YAMAUCHI SHOJI; SAKAI SHIZUYOSHI, J. CHEM. SOC. PERKIN TRANS.,(1986) N 11, 1929-1932
    作者:FUKUZAWA SHIN-ICHI、 FUJINAMI TATSUO、 YAMAUCHI SHOJI、 SAKAI SHIZUYOSHI
    DOI:——
    日期:——
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
raman
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸